Effect of Serum Heat-Inactivation and Dilution on Detection of Anti-WNV Antibodies in Mice by West Nile Virus E-protein Microsphere Immunoassay

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Namekar, Madhuri ^a   Kumar, Mukesh ^a   O'Connell, Maile ^a   Nerurkar, Vivek R ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICROSPHERE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS E PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DILUTION; FLAVIVIRUS INFECTION; HEAT TREATMENT; IMMUNOASSAY; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; PROCESS OPTIMIZATION; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, VIRAL; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HOT TEMPERATURE; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, INBRED C57BL; MICROSPHERES; NEUTRALIZATION TESTS; SENSITIVITY AND SPECIFICITY; WEST NILE FEVER; WEST NILE VIRUS;

MUS; WEST NILE VIRUS;

EID: 84866675230     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045851     Document Type: Article

References (39)

1. Brinton MA, (2002) The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol 56: 371-402.
2. Centers for Disease Control and Prevention (2002) Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion-Michigan, 2002. MMWR Morb Mortal Wkly Rep 51: 879.
3. Centers for Disease Control and Prevention (2002) Possible West Nile virus transmission to an infant through breast-feeding-Michigan, 2002. MMWR Morb Mortal Wkly Rep 51: 877-878.
4. Beasley DW, (2011) Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus. Immunotherapy 3: 269-285.
5. Diamond MS, Mehlhop E, Oliphant T, Samuel MA, (2009) The host immunologic response to West Nile encephalitis virus. Front Biosci 14: 3024-3034.
6. Sitati E, McCandless EE, Klein RS, Diamond MS, (2007) CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis. J Virol 81: 9801-9811.
7. Wong SJ, Boyle RH, Demarest VL, Woodmansee AN, Kramer LD, et al. (2003) Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol 41: 4217-4223.
8. Wong SJ, Demarest VL, Boyle RH, Wang T, Ledizet M, et al. (2004) Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol 42: 65-72.
9. Prince HE, Lape-Nixon M, Yeh C, Tobler LH, Busch MP, (2008) Persistence of antibodies to West Nile virus nonstructural protein 5. J Clin Virol 43: 102-106.
10. Appler KK, Brown AN, Stewart BS, Behr MJ, Demarest VL, et al. (2010) Persistence of West Nile virus in the central nervous system and periphery of mice. PLoS One 5: e10649.
11. Stewart BS, Demarest VL, Wong SJ, Green S, Bernard KA, (2011) Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection. BMC Immunol 12: 6.
12. Jones LP, Zheng HQ, Karron RA, Peret TC, Tsou C, et al. (2002) Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus. Clin Diagn Lab Immunol 9: 633-638.
13. Bellisario R, Colinas RJ, Pass KA, (2001) Simultaneous measurement of antibodies to three HIV-1 antigens in newborn dried blood-spot specimens using a multiplexed microsphere-based immunoassay. Early Hum Dev 64: 21-25.
14. Johnson AJ, Cheshier RC, Cosentino G, Masri HP, Mock V, et al. (2007) Validation of a microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin M antibodies. Clin Vaccine Immunol 14: 1084-1093.
15. Dias D, Van Doren J, Schlottmann S, Kelly S, Puchalski D, et al. (2005) Optimization and validation of a multiplexed Luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18. Clin Diagn Lab Immunol 12: 959-969.
16. Go YY, Wong SJ, Branscum AJ, Demarest VL, Shuck KM, et al. (2008) Development of a fluorescent-microsphere immunoassay for detection of antibodies specific to equine arteritis virus and comparison with the virus neutralization test. Clin Vaccine Immunol 15: 76-87.
17. Watson DS, Reddy SM, Brahmakshatriya V, Lupiani B, (2009) A multiplexed immunoassay for detection of antibodies against avian influenza virus. J Immunol Methods 340: 123-131.
18. Fang Y, Brault AC, Reisen WK, (2009) Comparative thermostability of West Nile, St. Louis encephalitis, and western equine encephalomyelitis viruses during heat inactivation for serologic diagnostics. Am J Trop Med Hyg 80: 862-863.
19. Karakus R, Buyrukcu BA, Aybay C, (2005) A new efficient method for eliminating the interference effect of human serum and increasing the sensitivity and recovery rate of enzyme immunoassay. J Immunoassay Immunochem 26: 109-124.
20. Papp K, Szekeres Z, Terenyi N, Isaak A, Erdei A, et al. (2007) On-chip complement activation adds an extra dimension to antigen microarrays. Mol Cell Proteomics 6: 133-140.
21. Schnaidt M, Weinstock C, Jurisic M, Schmid-Horch B, Ender A, et al. (2011) HLA antibody specification using single-antigen beads-a technical solution for the prozone effect. Transplantation 92: 510-515.
22. Perkins J, Parida S, Clavijo A, (2007) Use of a standardized bovine serum panel to evaluate a multiplexed nonstructural protein antibody assay for serological surveillance of foot-and-mouth disease. Clin Vaccine Immunol 14: 1472-1482.
23. Weber TH, Kapyaho KI, Tanner P, (1990) Endogenous Interference in Immunoassays in Clinical-Chemistry- a Review. Scand J Clin Lab Invest 50: 77-82.
24. McHugh TM, Miner RC, Logan LH, Stites DP, (1988) Simultaneous detection of antibodies to cytomegalovirus and herpes simplex virus by using flow cytometry and a microsphere-based fluorescence immunoassay. J Clin Microbiol 26: 1957-1961.
25. Martins TB, Litwin CM, Hill HR, (2008) Evaluation of a multiplex fluorescent microsphere immunoassay for the determination of epstein-barr virus serologic status. Am J Clin Pathol 129: 34-41.
26. Roe K, Kumar M, Lum S, Orillo B, Nerurkar VR, et al. (2012) West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J Gen Virol.
27. Verma S, Molina Y, Lo YY, Cropp B, Nakano C, et al. (2008) In vitro effects of selenium deficiency on West Nile virus replication and cytopathogenicity. Virol J 5: 66.
28. Ledizet M, Kar K, Foellmer HG, Wang T, Bushmich SL, et al. (2005) A recombinant envelope protein vaccine against West Nile virus. Vaccine 23: 3915-3924.
29. Lieberman MM, Nerurkar VR, Luo H, Cropp B, Carrion R Jr, et al. (2009) Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin Vaccine Immunol 16: 1332-1337.
30. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, et al. (2003) A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med 198: 1853-1862.
31. Tesh RB, Siirin M, Guzman H, Travassos da Rosa AP, Wu X, et al. (2005) Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis 192: 287-295.
32. Roehrig JT, Nash D, Maldin B, Labowitz A, Martin DA, et al. (2003) Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 9: 376-379.
33. Papa A, Danis K, Athanasiadou A, Delianidou M, Panagiotopoulos T, (2011) Persistence of West Nile virus immunoglobulin M antibodies, Greece. J Med Virol 83: 1857-1860.
34. Schwenk JM, Nilsson P, (2011) Antibody suspension bead arrays. Methods Mol Biol 723: 29-36.
35. Johnson AJ, Noga AJ, Kosoy O, Lanciotti RS, Johnson AA, et al. (2005) Duplex microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodies. Clin Diagn Lab Immunol 12: 566-574.
36. Balasuriya UB, Shi PY, Wong SJ, Demarest VL, Gardner IA, et al. (2006) Detection of antibodies to West Nile virus in equine sera using microsphere immunoassay. J Vet Diagn Invest 18: 392-395.
37. Lowe D, Hathaway M, Briggs D, (2007) The high-dose hook effect in the detection and monitoring of HLA specific antibody by Luminex assay. Int J Immunogenet 34: 288-288.
38. Schetters T, Van Run-Van Breda J, Van Zon A, Eling W, (1988) Selective depletion of immunoglobulin isotypes after decomplementation of mouse sera by heat treatment. J Immunol Methods 109: 193-197.
39. Tate J, Ward G, (2004) Interferences in immunoassay. Clin Biochem Rev 25: 105-120.